Dietrich von Schweinitz
Overview
Explore the profile of Dietrich von Schweinitz including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
130
Citations
2849
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Espinoza A, Bagatell R, McHugh K, Naranjo A, Van Ryn C, Rojas Y, et al.
Pediatr Blood Cancer
. 2024 Jul;
71(10):e31218.
PMID: 39072986
Background: Image-defined risk factors (IDRFs) were promulgated for predicting the feasibility and safety of complete primary tumor resection in children with neuroblastoma (NB). There is limited understanding of the impact...
2.
Schultewolter J, Rissmann A, von Schweinitz D, Fruhwald M, Blattmann C, Fischer L, et al.
Cancers (Basel)
. 2024 Jun;
16(11).
PMID: 38893276
GCTs are developmental tumors and are likely to reflect ontogenetic and teratogenetic determinants. The objective of this study was to identify syndromes with or without congenital anomalies and non-syndromic defects...
3.
Meier C, Furtwangler R, Welter N, Mergen M, Wagenpfeil S, von Schweinitz D, et al.
Ann Surg
. 2024 Jun;
PMID: 38864214
Objective: This study aimed to identify parameters that allow the estimation of tumor-infiltrated lymph nodes (LN) after pretreatment for unilateral Wilms tumor (WT). Summary Background Data: Complete tumor resection with...
4.
Maxwell R, Haberle B, Kappler R, von Schweinitz D, Rassner M, von Frowein J, et al.
Cancers (Basel)
. 2024 Feb;
16(4).
PMID: 38398087
Survival rates for HB patients have improved; however, outcomes for patients who relapse remain poor. A retrospective review of information gathered for the HB99 study and the German Liver Tumor...
5.
Muehling J, Froba-Pohl A, Muensterer O, von Schweinitz D, Kappler R
Eur J Pediatr Surg
. 2023 Sep;
34(1):69-77.
PMID: 37774735
Objective: The antiapoptotic BCL-2 protein has implications for maturation and differentiation of neural tissue and acts as a strong modulator of carcinogenesis in different tumors. Recent research focuses not only...
6.
Ritter J, Lisec K, Klinner M, Heinrich M, von Schweinitz D, Kappler R, et al.
Children (Basel)
. 2023 May;
10(5).
PMID: 37238430
VACTERL association is a rare malformation complex consisting of vertebral defects, anorectal malformation, cardiovascular defects, tracheoesophageal fistulae with esophageal atresia, renal malformation, and limb anomalies. According to current knowledge, VACTERL...
7.
Bergmann S, Ritz L, Widenmann-Grolig A, Jechalke S, von Schweinitz D, Hubertus J, et al.
Eur J Pediatr
. 2022 Nov;
182(1):275-283.
PMID: 36331620
Conclusion: In this national cohort of VLBW and ELBW preterm-born children with OA, swallowing-related quality of life is good, mostly independent of initial surgery. Children with OA and ICH or...
8.
Li Q, Demir S, Del Rio-Alvarez A, Maxwell R, Wagner A, Carrillo-Reixach J, et al.
Cancers (Basel)
. 2022 Sep;
14(17).
PMID: 36077733
Resistance to conventional chemotherapy remains a huge challenge in the clinical management of hepatoblastoma, the most common liver tumor in childhood. By integrating the gene expression data of hepatoblastoma patients...
9.
Surgical Factors Influencing Local Relapse and Outcome in the Treatment of Unilateral Nephroblastoma
Meier C, Fuchs J, von Schweinitz D, Stein R, Wagenpfeil S, Kager L, et al.
Ann Surg
. 2022 Aug;
278(2):e360-e367.
PMID: 36017935
Objective: This study aims to identify factors associated with the occurrence of local relapse (LR) after treatment for unilateral nephroblastoma. Background: Despite the fact that LR is rare (~5%) its...
10.
Meier C, Furtwangler R, von Schweinitz D, Stein R, Welter N, Wagenpfeil S, et al.
Cancers (Basel)
. 2022 Aug;
14(16).
PMID: 36010917
(1) Background: Vena cava thrombus (VCT) is rare in Wilms tumor (WT) (4−10%). The aim of this study is to identify factors for an outcome to improve treatment for better...